BREASTFEEDING

What are substitutes? What aspects are covered by the International Code of Marketing of Human Milk Substitutes?

Submitted by usuario.ops on Sun, 21/01/2024 - 21:23

The definition of the word “substitute” implies something that has properties similar to those of another thing and may replace it with a lesser degree of quality, or an imitation of lesser quality than the original.
A human milk substitute is any food marketed as a partial or total substitute for breast milk, and the elements for its administration, whether or not they are suitable for that purpose.
The International Code of Marketing of Human Milk Substitutes applies to marketing strategies for the following milk substitute products:

What is the International Code of Marketing of Human Milk Substitutes?

Submitted by usuario.ops on Fri, 12/01/2024 - 13:23

The International Code of Substitutes consists of a set of recommendations aimed at regulating the aggressive and improper marketing of human milk substitutes, bottles and teats, which compete with breastfeeding.
In 1981, the 34th World Health Assembly adopted the International Code of Marketing of Human Milk Substitutes as a minimum requirement to protect and promote adequate feeding of infants and young children.

Step 1. Why does the breastfeeding policy need to be written?

Submitted by usuario.ops on Wed, 10/01/2024 - 11:32

Having a written breastfeeding policy allows to:

- Make the various actors at the facilities agree to comply with practices that favor breastfeeding.
- Make the medical and nursing staff take ownership of the topic.
- Have recommendations applicable to specific environments.
- Monitor, evaluate and obtain data on breastfeeding practices and their effects, e.g., through audits.
- Exchange views within and outside the institution, involving more actors, sharing experiences and facilitating the replication of good practices.

Step 1. How to develop the breastfeeding policy

Submitted by usuario.ops on Wed, 10/01/2024 - 11:27

The development of the breastfeeding policy varies broadly; it should include breastfeeding experts and avoid commercial links with products and companies regulated by the International Code of Human Milk Substitutes.

A committee including high-level representation from all stakeholders may be appointed to develop the policy. Once the necessary agreements are reached, the committee should continue to monitor the proper implementation of the policy.

Step 1. What should be the characteristics of the standards and policies developed to strengthen breastfeeding at facilities?

Submitted by usuario.ops on Wed, 10/01/2024 - 10:35

Standards and policies to strengthen breastfeeding at birthing facilities should be written. This feature is important to sustain unanimity of criteria in practices.

Furthermore, the policy should consider the 10 steps set forth by the World Health Organization for successful breastfeeding, i.e.

- available for consultation by all personnel

- visibly displayed in all areas of the hospital

- written in the language(s) most frequently understood by patients and staff.

What is the relationship between skin-to-skin contact and breastfeeding?

Submitted by usuario.ops on Wed, 15/11/2023 - 21:07

Early skin-to-skin contact and early breastfeeding are two closely linked interventions that should be carried out immediately after birth.
Immediate and prolonged skin-to-skin contact facilitates lactation, enriches the microbiome of newborns, prevents hypothermia and hypoglycemia, and stabilizes respiratory function.
Early suckling at the breast stimulates lactogenesis II (activation of milk secretion) and transfers colostrum, rich in immunoactive substances, especially important for those born prematurely.

What needs to be done to establish and preserve the mother's own milk supply for preterm newborns admitted to the neonatal inpatient area?

Submitted by usuario.ops on Thu, 09/11/2023 - 10:27

When a child is born prematurely, some things are important to initiate and sustain the mother’s milk production:


- In the birthing area:
• Immediate, direct and continuous skin-to-skin contact, whenever clinically possible.
• Extraction of colostrum for administration into the newborn’s oropharynx.